NWQ Investment Management Company’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,243,252
Closed -$18.6M 201
2016
Q2
$18.6M Buy
+1,243,252
New +$16M 0.32% 94
2015
Q2
Sell
-72,373
Closed -$1.68M 164
2015
Q1
$1.68M Sell
72,373
-453,118
-86% -$12M 0.02% 146
2014
Q4
$13.2M Buy
525,491
+8,165
+2% +$240K 0.16% 102
2014
Q3
$16.1M Sell
517,326
-284,695
-35% -$7.71M 0.18% 105
2014
Q2
$20.7M Sell
802,021
-53,729
-6% -$1.19M 0.21% 98
2014
Q1
$20M Buy
855,750
+179,815
+27% +$3.93M 0.17% 93
2013
Q4
$17.2M Buy
+675,935
New +$15.3M 0.15% 96

NWQ Investment Management Company's SGNT Position: Q3 2016 in Review

NWQ Investment Management Company sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,243,252 shares — an estimated $18.6M sold.

NWQ Investment Management Company first reported a position in SGNT in Q4 2013 and held it in 7 quarters. The position peaked at $20.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • NWQ Investment Management Company reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • NWQ Investment Management Company sold 1,243,252 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $18.6M.
  • NWQ Investment Management Company first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 7 quarters.
  • NWQ Investment Management Company's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $20.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on NWQ Investment Management Company's 13F filing for Q3 2016, filed 14 Nov 2016.